Brief: Pixium Vision: Activation Of Photovoltaic Prima Implant In All Five Study Patients
30/08/2018 06:14
Aug 30 (Reuters) - PIXIUM VISION SA PIX.PA :
* REG-PIXIUM VISION ACHIEVES SUCCESSFUL ACTIVATION OF ITS
PHOTOVOLTAIC PRIMA IMPLANT neIN ALL FIVE STUDY PATIENTS WITH DRY
AGE-RELATED MACULAR DEGENERATION
* FULL SET OF 6-MONTH INTERIM RESULTS OF FRENCH FEASIBILITY
STUDY
ARE EXPECTED BY END OF 2018 AS PLANNED
* DESIGN OF PROTOCOL FOR LARGER MULTI-CENTRIC EUROPEAN
PIVOTAL
STUDY, WHICH IS REQUIRED FOR CE-MARK, TO COMMENCE IN 2019
Source text for Eikon: ID:nGNE6vj6BD
Further company coverage: PIX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow